Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
A Andrades, P Peinado, JC Alvarez-Perez… - Molecular cancer, 2023 - Springer
Hematological malignancies are a highly heterogeneous group of diseases with varied
molecular and phenotypical characteristics. SWI/SNF (SWItch/Sucrose Non-Fermentable) …
molecular and phenotypical characteristics. SWI/SNF (SWItch/Sucrose Non-Fermentable) …
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
N Pemmaraju, H Kantarjian, K Sweet, E Wang… - Blood, 2023 - ashpublications.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
A Künstner, J Schwarting, HM Witte, P **ng, V Bernard… - Leukemia, 2024 - nature.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) constitutes a rare and aggressive
malignancy originating from plasmacytoid dendritic cells (pDCs) with a primarily cutaneous …
malignancy originating from plasmacytoid dendritic cells (pDCs) with a primarily cutaneous …
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
E Shumilov, P Mazzeo, S Ghandili, A Künstner… - Annals of …, 2024 - Springer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare malignancy derived from
plasmacytoid dendritic cells, can mimic both acute leukemia and aggressive T-cell …
plasmacytoid dendritic cells, can mimic both acute leukemia and aggressive T-cell …
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone
S Denker, A Künstner, J Schwarting, HM Witte… - Leukemia, 2024 - nature.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive blood
cancer that originates from clonal pDCs or their precursors. A shared clonal origin between …
cancer that originates from clonal pDCs or their precursors. A shared clonal origin between …
Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models
M Kaehler, P Osteresch, A Künstner, SJ Vieth… - Frontiers in …, 2023 - frontiersin.org
Introduction Resistance in anti-cancer treatment is a result of clonal evolution and clonal
selection. In chronic myeloid leukemia (CML), the hematopoietic neoplasm is predominantly …
selection. In chronic myeloid leukemia (CML), the hematopoietic neoplasm is predominantly …
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged organ-tropism
A Künstner, V von Kopylow, P Lohneis, M Kuemmel… - medRxiv, 2024 - medrxiv.org
Primary renal manifestations of diffuse large B-cell lymphoma (PR-DLBCL) represent an
exceptionally rare variant of the most common type of non-Hodgkin lymphoma (NHL) …
exceptionally rare variant of the most common type of non-Hodgkin lymphoma (NHL) …
Genome-wide DNA methylation-analysis delineates blastic plasmacytoid dendritic cell neoplasm from related entities and identifies distinct molecular features
A Künstner, J Schwarting, HM Witte, P **ng, V Bernard… - medRxiv, 2023 - medrxiv.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) constitutes a rare and aggressive
malignancy originating from plasmacytoid/common dendritic cells (pDCs/cDCs) with a …
malignancy originating from plasmacytoid/common dendritic cells (pDCs/cDCs) with a …
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Á Andrades Delgado, P Peinado Fernández… - 2023 - digibug.ugr.es
Hematological malignancies are a highly heterogeneous group of diseases with varied
molecular and phenotypical characteristics. SWI/SNF (SWItch/Sucrose Non-Fermentable) …
molecular and phenotypical characteristics. SWI/SNF (SWItch/Sucrose Non-Fermentable) …
[Цитат][C] Chronic myelomonocytic leukemia transdifferentiation landscape: From histiocytosis to blastic plasmacytoid dendritic cell neoplasm
G Antherieu, M Donzel, B Balme… - American Journal of …, 2023 - Wiley Online Library
A 70-year-old man presented with splenomegaly, weight loss, and cytopenias. Marrow
assessment led to the diagnosis of chronic myelomonocytic leukemia (CMML)(Image 1A …
assessment led to the diagnosis of chronic myelomonocytic leukemia (CMML)(Image 1A …